Geographic Atrophy
📧 Sign up to get email alerts when something new happens for Geographic Atrophy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy [Phase 1, Phase 2]
Ocugen is conducting a Phase 1/2 trial to assess the safety and efficacy of OCU410 for geographic atrophy. The study status is active but no…
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD [Phase 2]
A Phase 2 study evaluating ONL1204 for geographic atrophy associated with age-related macular degeneration is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Multiple Dose Study of AVD-104 for Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) [Phase 2]
This document provides a Phase 2 multiple-dose trial update for AVD-104 in geographic atrophy secondary to age-related macular degeneration,…
-
CLINICAL_TRIALS research · 2025-06-26Clinical Trial Update: A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the oral agent BRX011 for geographic atrophy due to age-related macular degeneration; the study is not…
-
CLINICAL_TRIALS research · 2025-06-13Clinical Trial Update: Investigating Geographic Atrophy Insights (i-GAIN) Natural History Study
An ongoing natural history study (i-GAIN) on geographic atrophy in dry age-related macular degeneration is active but not recruiting. The st…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Personalized Monitoring of Non-foveal, Non-vision Compromising Atrophic Age-related Macular Degeneration With Artificial Intelligence and Identification of Disease Progression
A clinical trial update from the Medical University of Vienna describes a study evaluating AI-assisted personalized monitoring of non-foveal…
-
CLINICAL_TRIALS research · 2025-04-22Clinical Trial Update: High Resolution Retinal Imaging
A University of Pennsylvania-sponsored clinical trial using high-resolution retinal imaging is currently recruiting participants for several…
-
CLINICAL_TRIALS research · 2025-03-24Clinical Trial Update: A Prospective Observational Study to Assess the Reliability and Validity of the MLSDT
A prospective observational study to assess the reliability and validity of the MLSDT for macular degeneration-related conditions, currently…
-
CLINICAL_TRIALS research · 2025-01-08Clinical Trial Update: Observational Study to Assess Endpoint Operational Feasibility & Measurement Properties in Patients with Retinal Degeneration
This clinical trial update describes an observational study to assess endpoint feasibility and measurement properties in patients with retin…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD [NA]
A multicenter clinical study investigating SING-IMT for late-stage age-related macular degeneration, including geographic atrophy, is curren…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD [NA]
Update on a clinical trial evaluating the PRIMA System to restore central vision in geographic atrophy due to age-related macular degenerati…
-
CLINICAL_TRIALS research · 2024-09-24Clinical Trial Update: Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration. [Phase 1, Phase 2]
This clinical trial update notes that Eyestem Research's Eyecyte-RPE is currently recruiting Phase 1/2 participants to evaluate safety and e…
-
CLINICAL_TRIALS research · 2022-11-04Clinical Trial Update: Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) [Phase 2, Phase 3]
Clinical trial update for ORACEA in geographic atrophy (Phase 2/3) is completed.
-
CLINICAL_TRIALS research · 2015-02-26Clinical Trial Update: Geographic Atrophy and Intravitreal Ranibizumab Injections
This entry reports a clinical trial update evaluating intravitreal ranibizumab injections for geographic atrophy in age-related macular dege…
-
CLINICAL_TRIALS research · 2013-07-01Clinical Trial Update: Repeatability and Reproducibility of Cirrus HD-OCT Measurements of Illumination Areas Under the Retinal Pigment Epithelium
This clinical trial update evaluates the repeatability and reproducibility of Cirrus HD-OCT measurements of illumination areas under the ret…